Bayer Schering links with TauRx for Alzheimer's imaging technology
This article was originally published in Scrip
Executive Summary
Bayer Schering Pharma (BSP) has entered into a collaborative R&D agreement with the Singapore venture TauRx Pharmaceuticals for research into Alzheimer's disease biomarkers.